Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner
Megan E. Bosch, Hemraj B. Dodiya, Julia Michalkiewicz, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 129
Parental origin of transgene modulates amyloid-β plaque burden in the 5xFAD mouse model of Alzheimer’s disease
Andrew Octavian Sasmita, Erinne Cherisse Ong, T. I. Nazarenko, et al.
Neuron (2025) Vol. 113, Iss. 6, pp. 838-846.e4
Open Access | Times Cited: 4
Sex‐specific associations between AD genotype and the microbiome of human amyloid beta knock‐in (hAβ‐KI) mice
Sage J. B. Dunham, Julio Avelar‐Barragan, Jason A. Rothman, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4935-4950
Open Access | Times Cited: 7
Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer’s Disease: A Review
Lee Jy, Chiew-Yen Wong, Rhun Yian Koh, et al.
The Yale Journal of Biology and Medicine (2024) Vol. 97, Iss. 2, pp. 205-224
Open Access | Times Cited: 6
Microbiota-derived lysophosphatidylcholine alleviates Alzheimer’s disease pathology via suppressing ferroptosis
Xu Zha, Xicheng Liu, Mengping Wei, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 6
Dietary Methionine Restriction Alleviates Cognitive Impairment in Alzheimer’s Disease Mice via Sex-Dependent Modulation on Gut Microbiota and Tryptophan Metabolism: A Multiomics Analysis
Yuyu Zhang, Tianqi Liu, Fei Pan, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Polymers for the treatment of Alzheimer’s disease
Yunfeng Zhu, Haibin Xu, Canqing Yu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The Advancements of Marine Natural Products in the Treatment of Alzheimer’s Disease: A Study Based on Cell and Animal Experiments
Chunbo Jia, Jian Chai, Shenyun Zhang, et al.
Marine Drugs (2025) Vol. 23, Iss. 3, pp. 91-91
Open Access
How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells
Philipp Schaible, Julia Henschel, Daniel Erny
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
The role of gut microbiota‐derived metabolites in neuroinflammation
Lingjie Mu, Yijie Wang
Neuroprotection/Neuroprotection (Chichester, England. Print) (2025)
Open Access
The Oral–Gut Microbiome–Brain Axis in Cognition
Noorul Ain Adil, Christabel Omo-Erigbe, Hariom Yadav, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 814-814
Open Access
Gut-Brain Axis and a Systematic Approach to Alzheimer’s Disease Therapies
Jinhe Li, Huilin Mou, Ranran Yao
Brain Science Advances (2025) Vol. 11, Iss. 1
Open Access
Alzheimer's Disease Has Its Origins in Early Life via a Perturbed Microbiome
Stephen D. Ginsberg, Martin J. Blaser
The Journal of Infectious Diseases (2024) Vol. 230, Iss. Supplement_2, pp. S141-S149
Closed Access | Times Cited: 2
The mechanisms, hallmarks, and therapies for brain aging and age-related dementia
Shiyun Jin, Wenping Lü, Juan Zhang, et al.
Science Bulletin (2024)
Closed Access | Times Cited: 2
Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?
Shanshan Zhang, Jing Lu, Ziqi Jin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Sodium oligomannate disrupts the adherence of Ribhigh bacteria to gut epithelia to block SAA-triggered Th1 inflammation in 5XFAD transgenic mice
Xinyi Wang, Zuoquan Xie, Jie Yuan, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target
Nidhi Puranik, Minseok Song
Molecules (2024) Vol. 29, Iss. 23, pp. 5744-5744
Open Access | Times Cited: 2
Gut microbiota dysbiosis and neurologic diseases: New Horizon with potential diagnostic and therapeutic impact
Ali Keshavarzian, Sangram S. Sisodia
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00478-e00478
Closed Access | Times Cited: 1
Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer ’s disease: A systematic review and network meta- analysis
Weili Cao, Bo Zhu, Zhiqin Liu, et al.
Neuroscience (2024) Vol. 565, pp. 29-39
Closed Access | Times Cited: 1
Sodium oligomannate’s amelioration of reproductive and metabolic phenotypes in a letrozole-induced PCOS-like mouse model depends on the gut microbiome
Zhi Li, Yan Liu, Yang Wang, et al.
Biology of Reproduction (2024) Vol. 111, Iss. 2, pp. 361-375
Closed Access
The Role of the Intestinal Flora and Its Derivatives in Neurocognitive Disorders: A Narrative Review from Surgical Perspective
Jian Huang, T Qin, Yun Bo, et al.
Molecular Neurobiology (2024)
Open Access
Sex differences and testosterone interfere with the structure of the gut microbiota through the bile acid signaling pathway
Xueqing Duan, You-Qi Nie, Xin Xie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Chemical Synthesis of β‐(1,4)‐d‐Oligomannurarates with Purported Anti‐Alzheimer Activity
Xiaofei Shao, Peng Xu, Biao Yu
European Journal of Organic Chemistry (2024)
Open Access
Page 1

Scroll to top